-
1
-
-
30144439616
-
A PANorama of PAX genes in cancer and development
-
Robson E.J., He S.J., and Eccles M.R. A PANorama of PAX genes in cancer and development. Nat. Rev. Cancer 6 1 (2006) 52-62
-
(2006)
Nat. Rev. Cancer
, vol.6
, Issue.1
, pp. 52-62
-
-
Robson, E.J.1
He, S.J.2
Eccles, M.R.3
-
2
-
-
0036368098
-
PAX genes in development and disease: the role of PAX2 in urogenital tract development
-
Eccles M.R., HE S., Legge M., Kumar R., Fox J., Zhou C., French M., and Tsai R.W. PAX genes in development and disease: the role of PAX2 in urogenital tract development. Int. J. Dev. Biol. 46 4 (2002) 535-544
-
(2002)
Int. J. Dev. Biol.
, vol.46
, Issue.4
, pp. 535-544
-
-
Eccles, M.R.1
HE, S.2
Legge, M.3
Kumar, R.4
Fox, J.5
Zhou, C.6
French, M.7
Tsai, R.W.8
-
4
-
-
0032885363
-
Pax2 in development and renal disease
-
Dressler G.R., and Woolf A.S. Pax2 in development and renal disease. Int. J. Dev. Biol. 43 5 (1999) 463-468
-
(1999)
Int. J. Dev. Biol.
, vol.43
, Issue.5
, pp. 463-468
-
-
Dressler, G.R.1
Woolf, A.S.2
-
5
-
-
0345687911
-
WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2
-
Discenza M.T., He S., Lee T.H., Chu L.L., Bolon B., Goodyer P., Eccles M.R., and Pelletier J. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene 22 50 (2003) 8145-8155
-
(2003)
Oncogene
, vol.22
, Issue.50
, pp. 8145-8155
-
-
Discenza, M.T.1
He, S.2
Lee, T.H.3
Chu, L.L.4
Bolon, B.5
Goodyer, P.6
Eccles, M.R.7
Pelletier, J.8
-
6
-
-
0030738544
-
Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2
-
McConnell M.J., Cunliffe H.E., Chua L.J., Ward T.A., and Eccles M.R. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene 14 22 (1997) 2689-2700
-
(1997)
Oncogene
, vol.14
, Issue.22
, pp. 2689-2700
-
-
McConnell, M.J.1
Cunliffe, H.E.2
Chua, L.J.3
Ward, T.A.4
Eccles, M.R.5
-
7
-
-
0034985617
-
Expression of the developmental and oncogenic PAX2 gene in human prostate cancer
-
Khoubehi B., Kessling A.M., Adshead J.M., Smith G.L., Smith R.D., and Ogden C.W. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J. Urol. 165 6 Pt. 1 (2001) 2115-2120
-
(2001)
J. Urol.
, vol.165
, Issue.6 PART 1
, pp. 2115-2120
-
-
Khoubehi, B.1
Kessling, A.M.2
Adshead, J.M.3
Smith, G.L.4
Smith, R.D.5
Ogden, C.W.6
-
8
-
-
0344255673
-
Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival
-
Muratovska A., Zhou C., He S., Goodyer P., and Eccles M.R. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 22 39 (2003) 7989-7997
-
(2003)
Oncogene.
, vol.22
, Issue.39
, pp. 7989-7997
-
-
Muratovska, A.1
Zhou, C.2
He, S.3
Goodyer, P.4
Eccles, M.R.5
-
9
-
-
0034622048
-
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR
-
Margure C.M., Bernasconi M., Barr F.G., and Schafer B.W. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene 19 (2000) 2921-2929
-
(2000)
Oncogene
, vol.19
, pp. 2921-2929
-
-
Margure, C.M.1
Bernasconi, M.2
Barr, F.G.3
Schafer, B.W.4
-
10
-
-
0032549828
-
Dependence of BSAP repressor and activator functions on BSAP concentration
-
Wallin J.J., Gackstetter E.R., and Koshland M.E. Dependence of BSAP repressor and activator functions on BSAP concentration. Science 279 (1998) 1961-1964
-
(1998)
Science
, vol.279
, pp. 1961-1964
-
-
Wallin, J.J.1
Gackstetter, E.R.2
Koshland, M.E.3
-
11
-
-
0343920679
-
A novel paired domain DNA recognition motif can mediate Pax2 repression of gene transcription
-
Havik B., Ragnhildstveit E., Lorens J.B., Saelemyr K., Fauske O., Knudsen L.K., and Fjose A. A novel paired domain DNA recognition motif can mediate Pax2 repression of gene transcription. Biochem. Biophys. Res. Commun. 266 2 (1999) 532-541
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.266
, Issue.2
, pp. 532-541
-
-
Havik, B.1
Ragnhildstveit, E.2
Lorens, J.B.3
Saelemyr, K.4
Fauske, O.5
Knudsen, L.K.6
Fjose, A.7
-
12
-
-
0029874066
-
C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (PAX-5), PAX-2 and PAX-8
-
Dorfler P., and Busslinger M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (PAX-5), PAX-2 and PAX-8. EMBO J. 15 8 (1996) 1971-1982
-
(1996)
EMBO J.
, vol.15
, Issue.8
, pp. 1971-1982
-
-
Dorfler, P.1
Busslinger, M.2
-
13
-
-
0036382967
-
Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member
-
Yuan S.S., Yeh Y.T., and Lee E.Y. Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member. Biochem. Biophys. Res. Commun. 296 4 (2002) 1019-1025
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.296
, Issue.4
, pp. 1019-1025
-
-
Yuan, S.S.1
Yeh, Y.T.2
Lee, E.Y.3
-
14
-
-
0029834212
-
The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1)
-
Dhebi M., Ghahremani M., Lechner M., Dressler G.R., and Pelletier J. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 13 (1996) 447-453
-
(1996)
Oncogene
, vol.13
, pp. 447-453
-
-
Dhebi, M.1
Ghahremani, M.2
Lechner, M.3
Dressler, G.R.4
Pelletier, J.5
-
15
-
-
0028809870
-
Loss of p53 function through PAX-mediated transcriptional repression
-
Stuart E.T., Haffner R., Oren M., and Gruss P. Loss of p53 function through PAX-mediated transcriptional repression. EMBO J. 14 22 (1995) 5638-5645
-
(1995)
EMBO J.
, vol.14
, Issue.22
, pp. 5638-5645
-
-
Stuart, E.T.1
Haffner, R.2
Oren, M.3
Gruss, P.4
-
16
-
-
18144364007
-
Death squads enlisted by the tumour suppressor p53
-
Michalak E., Villunger A., Erlacher M., and Strasser A. Death squads enlisted by the tumour suppressor p53. Biochem. Biophys. Res. Commun. 331 3 (2005) 786-798
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.331
, Issue.3
, pp. 786-798
-
-
Michalak, E.1
Villunger, A.2
Erlacher, M.3
Strasser, A.4
-
17
-
-
0033967393
-
The role of p53-target genes in human cancer
-
Tokino T., and Nakamura Y. The role of p53-target genes in human cancer. Crit. Rev. Oncol. Hematol. 33 1 (2000) 1-6
-
(2000)
Crit. Rev. Oncol. Hematol.
, vol.33
, Issue.1
, pp. 1-6
-
-
Tokino, T.1
Nakamura, Y.2
-
18
-
-
0030560994
-
Pax genes and their roles in cell differentiation and development
-
Mansouri A., Hallonet M., and Gruss P. Pax genes and their roles in cell differentiation and development. Cur. Opin. Cell Biol. 8 (1996) 851-857
-
(1996)
Cur. Opin. Cell Biol.
, vol.8
, pp. 851-857
-
-
Mansouri, A.1
Hallonet, M.2
Gruss, P.3
-
19
-
-
0027401607
-
The multi-step nature of cancer
-
Vogelstein B., and Kinzler K.W. The multi-step nature of cancer. Trends Genet. 9 4 (1993) 138-141
-
(1993)
Trends Genet.
, vol.9
, Issue.4
, pp. 138-141
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
20
-
-
0036698536
-
Detection of genetic alterations in advanced prostate cancer by comparitive genomic hybridization
-
Kasahara K., Taguchi T., Yamasaki I., Kamada M., Yuri K., and Shuin T. Detection of genetic alterations in advanced prostate cancer by comparitive genomic hybridization. Cancer Genet. Cytogenet. 137 1 (2002) 59-63
-
(2002)
Cancer Genet. Cytogenet.
, vol.137
, Issue.1
, pp. 59-63
-
-
Kasahara, K.1
Taguchi, T.2
Yamasaki, I.3
Kamada, M.4
Yuri, K.5
Shuin, T.6
-
21
-
-
0029166712
-
Human bladder carcinoma lines as indicators of oncogenic change relevant to urothelial neoplastic progression
-
Reiger K.M., Little A.F., Swart J.M., Kastrinakis W.V., Fitzgerald J.M., Hess D.T., Libertino J.A., and Summerhayes I.C. Human bladder carcinoma lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br. J. Cancer 72 3 (1995) 683-690
-
(1995)
Br. J. Cancer
, vol.72
, Issue.3
, pp. 683-690
-
-
Reiger, K.M.1
Little, A.F.2
Swart, J.M.3
Kastrinakis, W.V.4
Fitzgerald, J.M.5
Hess, D.T.6
Libertino, J.A.7
Summerhayes, I.C.8
-
22
-
-
28744435101
-
Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells
-
Tepper C.G., Gregg J.P., Shi X.B., Vinall R.L., Baron C.A., Ryan P.E., Desprez P.Y., Kung H.J., and deVere-White R.W. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells. Prostate 65 4 (2005) 375-389
-
(2005)
Prostate
, vol.65
, Issue.4
, pp. 375-389
-
-
Tepper, C.G.1
Gregg, J.P.2
Shi, X.B.3
Vinall, R.L.4
Baron, C.A.5
Ryan, P.E.6
Desprez, P.Y.7
Kung, H.J.8
deVere-White, R.W.9
-
23
-
-
0035995333
-
Expression of nuclear transcription factor PAX2 in renal biopsies of juvenile nephronophthisis
-
Murer L., Caridi G., Della Vella M., Montini G., Carasi C., Ghiggeri G., and Zacchello G. Expression of nuclear transcription factor PAX2 in renal biopsies of juvenile nephronophthisis. Nephron 91 4 (2002) 588-593
-
(2002)
Nephron
, vol.91
, Issue.4
, pp. 588-593
-
-
Murer, L.1
Caridi, G.2
Della Vella, M.3
Montini, G.4
Carasi, C.5
Ghiggeri, G.6
Zacchello, G.7
-
24
-
-
0034642988
-
Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease
-
Ostrom L., Tang M.J., Gruss P., and Dressler G.R. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease. Dev. Biol. 219 2 (2000) 250-258
-
(2000)
Dev. Biol.
, vol.219
, Issue.2
, pp. 250-258
-
-
Ostrom, L.1
Tang, M.J.2
Gruss, P.3
Dressler, G.R.4
-
25
-
-
1042301418
-
Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells
-
Buttiglieri S., Deregibus M.C., Bravo S., Cassoni P., Chiarle R., Bussolati B., and Camussi G. Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J. Biol. Chem. 279 6 (2004) 4136-4143
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.6
, pp. 4136-4143
-
-
Buttiglieri, S.1
Deregibus, M.C.2
Bravo, S.3
Cassoni, P.4
Chiarle, R.5
Bussolati, B.6
Camussi, G.7
-
26
-
-
0029082823
-
Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides
-
Gnarra J.R., and Dressler G.R. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 55 18 (1995) 4092-4098
-
(1995)
Cancer Res.
, vol.55
, Issue.18
, pp. 4092-4098
-
-
Gnarra, J.R.1
Dressler, G.R.2
-
27
-
-
14944348965
-
The role of BH3-only proteins in the immune system
-
Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5 3 (2005) 189-200
-
(2005)
Nat. Rev. Immunol.
, vol.5
, Issue.3
, pp. 189-200
-
-
Strasser, A.1
-
28
-
-
0033515838
-
Differentially expressed genes in activin-induced apoptotic LNCaP cells
-
Lin S., and Ying S.Y. Differentially expressed genes in activin-induced apoptotic LNCaP cells. Biochem. Biophys. Res. Commun. 257 1 (1999) 187-192
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.257
, Issue.1
, pp. 187-192
-
-
Lin, S.1
Ying, S.Y.2
-
30
-
-
0037376405
-
The role of the Bcl-2 protein family in cancer
-
Coultas L., and Strasser A. The role of the Bcl-2 protein family in cancer. Semin. Cancer Biol. 13 2 (2003) 115-123
-
(2003)
Semin. Cancer Biol.
, vol.13
, Issue.2
, pp. 115-123
-
-
Coultas, L.1
Strasser, A.2
-
31
-
-
0034622048
-
Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR
-
Margue C.M., Bernasconi M., Barr F.G., and Schafer B.W. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene 19 25 (2003) 2921-2929
-
(2003)
Oncogene
, vol.19
, Issue.25
, pp. 2921-2929
-
-
Margue, C.M.1
Bernasconi, M.2
Barr, F.G.3
Schafer, B.W.4
-
32
-
-
1142299539
-
Isolation of p53-target genes and their functional analysis
-
Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 95 1 (2004) 7-11
-
(2004)
Cancer Sci.
, vol.95
, Issue.1
, pp. 7-11
-
-
Nakamura, Y.1
-
33
-
-
16844377411
-
Mitochondrial fusion and fission in the control of apoptosis
-
Perfettini J.L., Roumier T., and Kroemer G. Mitochondrial fusion and fission in the control of apoptosis. Trends Cell Biol. 15 4 (2005) 179-183
-
(2005)
Trends Cell Biol.
, vol.15
, Issue.4
, pp. 179-183
-
-
Perfettini, J.L.1
Roumier, T.2
Kroemer, G.3
-
35
-
-
0032475861
-
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
-
Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., and Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell Oct 2 95 1 (1998) 29-39
-
(1998)
Cell Oct 2
, vol.95
, Issue.1
, pp. 29-39
-
-
Stambolic, V.1
Suzuki, A.2
de la Pompa, J.L.3
Brothers, G.M.4
Mirtsos, C.5
Sasaki, T.6
Ruland, J.7
Penninger, J.M.8
Siderovski, D.P.9
Mak, T.W.10
-
36
-
-
0142075168
-
Molecular characterization of Human Prostate Carcinoma Cell Lines
-
Bodhoven A.V., Varella-Garcia M., Korch C., Johannes W.U., Smith E.E., Miller H.L., Nordeen S.K., Miller G.J., and Lucia M.S. Molecular characterization of Human Prostate Carcinoma Cell Lines. Prostate 57 (2003) 205-225
-
(2003)
Prostate
, vol.57
, pp. 205-225
-
-
Bodhoven, A.V.1
Varella-Garcia, M.2
Korch, C.3
Johannes, W.U.4
Smith, E.E.5
Miller, H.L.6
Nordeen, S.K.7
Miller, G.J.8
Lucia, M.S.9
-
37
-
-
0025940113
-
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
-
Isaacs W.B., Carter B.S., and Ewing C.M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 51 (1991) 4716-4720
-
(1991)
Cancer Res.
, vol.51
, pp. 4716-4720
-
-
Isaacs, W.B.1
Carter, B.S.2
Ewing, C.M.3
-
38
-
-
0027494237
-
p53 oncogene mutations in three human prostate cancer cell lines
-
Carroll A.G., Voeller H.J., Sugars L., and Gelmann E.P. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23 2 (1993) 123-134
-
(1993)
Prostate
, vol.23
, Issue.2
, pp. 123-134
-
-
Carroll, A.G.1
Voeller, H.J.2
Sugars, L.3
Gelmann, E.P.4
|